Tag: Vir Biotechnology
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of...
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – –...